Voloridge Investment Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,044
| Closed | -$585K | – | 1324 |
|
|
2023
Q3 | $585K | Sell |
5,044
-11,006
| -69% | -$1.28M | ﹤0.01% | 1188 |
|
|
2023
Q2 | $1.88M | Buy |
+16,050
| New | +$1.88M | 0.01% | 998 |
|
|
2022
Q1 | – | Sell |
-26,517
| Closed | -$1.86M | – | 1553 |
|
|
2021
Q4 | $1.86M | Buy |
+26,517
| New | +$1.86M | 0.01% | 1102 |
|
|
2021
Q3 | – | Sell |
-5,604
| Closed | -$381K | – | 1755 |
|
|
2021
Q2 | $381K | Buy |
+5,604
| New | +$381K | ﹤0.01% | 1483 |
|
|
2020
Q2 | – | Sell |
-4,800
| Closed | -$208K | – | 1390 |
|
|
2020
Q1 | $208K | Sell |
4,800
-1,306
| -21% | -$56.6K | 0.01% | 942 |
|
|
2019
Q4 | $338K | Buy |
+6,106
| New | +$338K | 0.01% | 903 |
|